119 related articles for article (PubMed ID: 22931162)
1. Comparative study on the in vitro cytotoxicity of linear, dendritic, and hyperbranched polylysine analogues.
Kadlecova Z; Baldi L; Hacker D; Wurm FM; Klok HA
Biomacromolecules; 2012 Oct; 13(10):3127-37. PubMed ID: 22931162
[TBL] [Abstract][Full Text] [Related]
2. DNA delivery with hyperbranched polylysine: a comparative study with linear and dendritic polylysine.
Kadlecova Z; Rajendra Y; Matasci M; Baldi L; Hacker DL; Wurm FM; Klok HA
J Control Release; 2013 Aug; 169(3):276-88. PubMed ID: 23379996
[TBL] [Abstract][Full Text] [Related]
3. Hyperbranched polylysine: a versatile, biodegradable transfection agent for the production of recombinant proteins by transient gene expression and the transfection of primary cells.
Kadlecova Z; Rajendra Y; Matasci M; Hacker D; Baldi L; Wurm FM; Klok HA
Macromol Biosci; 2012 Jun; 12(6):794-804. PubMed ID: 22496075
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.
Kaneshiro TL; Wang X; Lu ZR
Mol Pharm; 2007; 4(5):759-68. PubMed ID: 17705440
[TBL] [Abstract][Full Text] [Related]
5. Structural advantage of dendritic poly(L-lysine) for gene delivery into cells.
Yamagata M; Kawano T; Shiba K; Mori T; Katayama Y; Niidome T
Bioorg Med Chem; 2007 Jan; 15(1):526-32. PubMed ID: 17035030
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cell membrane disruption by pH-responsive pseudo-peptides through grafting with hydrophilic side chains.
Chen R; Yue Z; Eccleston ME; Williams S; Slater NK
J Control Release; 2005 Nov; 108(1):63-72. PubMed ID: 16139914
[TBL] [Abstract][Full Text] [Related]
7. Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker.
Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Owen DJ; Boyd BJ; Porter CJ
J Control Release; 2011 Jun; 152(2):241-8. PubMed ID: 21315119
[TBL] [Abstract][Full Text] [Related]
8. [The receptor of serpentine type and the heterotrimeric G protein as targets of action of the polylysine dendrimers].
Shpakov AO; Gur'ianov IA; Baianova NV; Vlasov GP
Tsitologiia; 2008; 50(12):1036-43. PubMed ID: 19198542
[TBL] [Abstract][Full Text] [Related]
9. ε-Polylysine and next-generation dendrigraft poly-L-lysine: chemistry, activity, and applications in biopharmaceuticals.
Shi C; He Y; Feng X; Fu D
J Biomater Sci Polym Ed; 2015; 26(18):1343-56. PubMed ID: 26381379
[TBL] [Abstract][Full Text] [Related]
10. Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differently.
Symonds P; Murray JC; Hunter AC; Debska G; Szewczyk A; Moghimi SM
FEBS Lett; 2005 Nov; 579(27):6191-8. PubMed ID: 16243317
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
Au JL; Li D; Gan Y; Gao X; Johnson AL; Johnston J; Millenbaugh NJ; Jang SH; Kuh HJ; Chen CT; Wientjes MG
Cancer Res; 1998 May; 58(10):2141-8. PubMed ID: 9605758
[TBL] [Abstract][Full Text] [Related]
12. Dendritic alpha,epsilon-poly(L-lysine)s as delivery agents for antisense oligonucleotides.
Eom KD; Park SM; Tran HD; Kim MS; Yu RN; Yoo H
Pharm Res; 2007 Aug; 24(8):1581-9. PubMed ID: 17373579
[TBL] [Abstract][Full Text] [Related]
13. Novel symmetric amphiphilic dendritic poly(L-lysine)-b-poly(L-lactide)-b-dendritic poly(L-lysine) with high plasmid DNA binding affinity as a biodegradable gene carrier.
Li Y; Cui L; Li Q; Jia L; Xu Y; Fang Q; Cao A
Biomacromolecules; 2007 May; 8(5):1409-16. PubMed ID: 17458996
[TBL] [Abstract][Full Text] [Related]
14. Peptide dendrimers as efficient and biocompatible gene delivery vectors: Synthesis and in vitro characterization.
Luo K; Li C; Wang G; Nie Y; He B; Wu Y; Gu Z
J Control Release; 2011 Oct; 155(1):77-87. PubMed ID: 20946920
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and inhibition study on tripeptide inhibitor modified poly(L-lysine) dendrimers.
Zhang X; Luo K; Wang G; Nie Y; He B; Wu Y; Gu Z
J Biomater Appl; 2012 Jul; 27(1):17-26. PubMed ID: 21123282
[TBL] [Abstract][Full Text] [Related]
16. Influence of polymer architecture and molecular weight of poly(2-(dimethylamino)ethyl methacrylate) polycations on transfection efficiency and cell viability in gene delivery.
Synatschke CV; Schallon A; Jérôme V; Freitag R; Müller AH
Biomacromolecules; 2011 Dec; 12(12):4247-55. PubMed ID: 22007721
[TBL] [Abstract][Full Text] [Related]
17. Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers.
Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Boyd BJ; Owen DJ; Porter CJ
Mol Pharm; 2011 Apr; 8(2):338-49. PubMed ID: 21171585
[TBL] [Abstract][Full Text] [Related]
18. RGD Conjugated Dendritic Polylysine for Cellular Delivery of Antisense Oligonucleotide.
Le TD; Nakagawa O; Fisher M; Juliano RL; Yoo H
J Nanosci Nanotechnol; 2017 Apr; 17(4):2353-357. PubMed ID: 29641161
[TBL] [Abstract][Full Text] [Related]
19. Short multi-armed polylysine-graft-polyamidoamine copolymer as efficient gene vectors.
Pan S; Wang C; Zeng X; Wen Y; Wu H; Feng M
Int J Pharm; 2011 Nov; 420(2):206-15. PubMed ID: 21893180
[TBL] [Abstract][Full Text] [Related]
20. Molecular level precision and high molecular weight peptide dendrimers for drug-specific delivery.
Fang X; Gao K; Huang J; Liu K; Chen L; Piao Y; Liu X; Tang J; Shen Y; Zhou Z
J Mater Chem B; 2021 Oct; 9(41):8594-8603. PubMed ID: 34705008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
